← SynDRA
LY303511
SynDRA canonical compound SYN1970533 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | BRD2 | BRD3 | BRD4 | CSNK2A1 | CSNK2A2 | CSNK2B | MTOR |
| Mechanism of action | casein kinase inhibitor | mTOR inhibitor | PI3K inhibitor |
All known targets
- BRD2
- BRD3
- BRD4
- CSNK2A1
- CSNK2A2
- CSNK2B
- MTOR
Mechanisms of action (all sources)
- casein kinase inhibitor
- MTOR inhibitor
- PI3K inhibitor
Cross-references
Synonyms
- ly-303511
- 2-Piperazinyl-8-phenyl-4H-1-benzopyran-4-one
- 8-phenyl-2-piperazin-1-ylchromen-4-one
- 8-phenyl-2-(piperazin-1-yl)-4h-chromen-4-one
- 8-Phenyl-2-Piperazin-1-Yl-Chromen-4-One
- CHEMBL1363184
- 4H-1-Benzopyran-4-one,8-phenyl-2-(1-piperazinyl)-
- 2-(4-Piperazinyl)-8-phenyl-4H-1-benzopyran-4-one
- SCHEMBL619297
- 2-(1-Piperazinyl)-8-phenyl-4H-1-benzopyran-4-one
- 8-Phenyl-2-(1-piperazinyl)-4H-1-benzopyran-4-one
- GTPL6005
- CHEBI:92399
- DTXSID90165632
- HMS3229G19
- HMS3269C09
- HMS3413M04
- HMS3677M04
- BCP08239
- EX-A1746
- ZINC2507616
- BDBM50210161
- NSC736787
- AKOS024457087
- CCG-206767
- CS-1384
- NSC-736787
- NCGC00161407-01
- NCGC00161407-02
- NCGC00161407-03
- NCGC00161407-08
- AC-32894
- BP-25363
- DA-33425
- HY-15643
- FT-0755982
- J-009102
- BRD-K22385716-001-01-7
- Q27082883
Look up LY303511 in the interactive SynDRA portal →